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Abstract 
Axon guidance is a crucial process for growth of the central and peripheral nervous systems.  In 
this study, 3 axon guidance related disorders, namely- Duane Retraction Syndrome (DRS) , 
Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS) and Congenital fibrosis of the 
extraocular muscles type 3 (CFEOM3) were studied using various Systems Biology tools to 
identify the genes and proteins involved with them to get a better idea about the underlying 
molecular mechanisms including the regulatory mechanisms. Based on the analyses carried out, 
7 significant modules have been identified from the PPI network. Five pathways/processes have 
been found to be significantly associated with DRS, HGPPS and CFEOM3 associated genes. 
From the PPI network, 3 have been identified as hub proteins- DRD2, UBC and CUL3.  
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Introduction 
Duane Retraction Syndrome (DRS) is a human genetic disorder of cranial nerve guidance (Engle 
2010). It’s a disorder of ocular motility involving deficient horizontal eye movements, eyelid 
retraction, palpebral fissure narrowing in adduction and a variety of other abnormal movement of 
the affected eye when the other eye is fixated in various cardinal positions (SHALABY and 
BAHGAT 2010; ALEXANDRAKIS and SAUNDERS 2001) .  The absence of 6
th
 cranial nerve 
and the consequent developmental adaptation that occurs in the embryo results in the abnormal 
pattern of ocular motility of DRS (SHALABY and BAHGAT 2010). 
Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS) is a clinically and genetically 
homogeneous disorder which is associated with failure of hindbrain axons to cross the midline 
(Engle 2010). Symptoms include being born with restricted horizontal gaze and development of 
scoliosis within the first decade of life. It results from mutations in the ROBO3 gene and is 
autosomal recessive in nature (Jen et al. 2004). 
Congenital fibrosis of the extraocular muscles type 3 (CFEOM3), an autosomal dominant 
congenital eye movement disorder involves variable unilateral or bilateral ophthalmoplegia, 
limited vertical ductions, and blepharoptosis (drooping eyelids) (Mackey et al. 2002). 
The purpose of this study was to identify crucial genes and proteins associated with Duane 
Retraction Syndrome (DRS), Horizontal Gaze Palsy with Progressive Scoliosis (HGPPS) and 
Congenital fibrosis of the extraocular muscles type 3 (CFEOM3) to get a better idea about the 
molecular mechanism, pathways and the key players. In order to do this, DRS, HGPPS and 
CFEOM3 associated genes from several databases were retrieved. Various Systems Biology 
tools have been put to use to carry out several analyses such as pathway enrichment analysis, 
protein-protein interaction (PPI) network, module analysis and identification of transcriptional 
regulators. 
 
Methods 
DRS, HGPPS and CFEOM3 associated genes  
 
The keywords “Duane Retraction Syndrome”, “HGPS”, and “Congenital fibrosis of the 
extraocular muscles type 3”  were used to screen out the genes associated with them from 3 
databases and  the results were put together to build a set of DRS, HGPPS and CFEOM3 
associated genes. The three databases used for finding the genes were- 
 
 GeneCards (version 3.0), a searchable, integrative database which provides 
comprehensive information on all annotated and predicted human genes (Safran et al. 
2010). 
 Search Tool for Interacting Chemicals (STICH, version 5.0), a database of known and 
predicted interactions between chemicals and proteins (Szklarczyk et al. 2016) 
 Comparative Toxicogenomics Database (CTD), which provides manually curated 
information concerning chemical–gene/protein interactions, chemical–disease as well as 
gene–disease relationships was used (Davis et al. 2017).   
 
 PPI Network  
 
Data from 2 interaction databases were merged in order to predict the Protein-Protein Interaction 
(PPI) pairs among the DRS, HGPPS and CFEOM3 associated genes. The databases were- 
 
 Biological General Repository for Interaction Datasets (BioGRID, version 
3.4, https://wiki.thebiogrid.org/) (Chatr-aryamontri et al. 2015) 
 The Molecular Interaction Database (MINT, 2012 update, https://mint.bio.uniroma2.it/) 
(Licata et al. 2012) 
 
Using the software Cytoscape (http://www.cytoscape.org) (Saito et al. 2012), a PPI network was 
visualized for DRS, HGPPS and CFEOM3 associated genes. 
 
Using the CytoNCA plug-in (Li et al. 2017) (version 
2.1.6, http://apps.cytoscape.org/apps/cytonca) in Cytoscape, degree centrality (DC), betweenness 
centrality (BC), and closeness centrality of the nodes of the PPI network were subjected to 
analysis to identify the hub proteins (He and Zhang n.d.). “Without weight.” was set as the 
parameter. 
 
Module Analysis 
 
For module analysis of the PPI network,  MCODE plug-in (Bader and Hogue 2003) (version 
1.4.2; http://apps.cytoscape.org/apps/mcode; parameters set as degree cut-off = 2, maximum 
depth = 100, node score cut-off = 0.2, and -core = 2) in Cytoscape was used.  
 
Pathway Enrichment Analysis 
 
KEGG pathway enrichment analysis for the nodes of top modules was carried out with 
JEPETTO plug-in (Winterhalter, Widera, and Krasnogor 2014) in Cytoscape.  
 
Identification of Transcriptional Regulators 
Transcription factors (TFs) of  DRS, HGPPS and CFEOM3 associated genes were searched and 
then their targets were identified using the transcriptional regulatory relationships unravelled by 
a sentence-based text-mining (TRRUST, http://www.grnpedia.org/trrust/) (Han et al. 2015) 
database.  
 
 
 
 
 
 
 
 
 
 
Results and Discussion 
 
 
 
Figure 1: Protein-protein interaction network of with DRS, HGPPS and CFEOM3 
associated genes. It contains 24,062 nodes (proteins) and 29,226 edges (interactions). 
 
Table 1: Axon guidance related disorder associated genes  
Duane Retraction Syndrome (DRS) 
 
Horizontal Gaze 
Palsy with 
Progressive 
Scoliosis (HGPPS) 
 
Congenital fibrosis 
of the extraocular 
muscle type3 
(CFEOM3) 
 
 
CHN1, MAFB, SALL4, SALL1, PAX2, TBX5, CHD7, 
KIF21A, BMP4, TBX3, TUBB3, ADNP, DPM1, HOXA1, 
SALL2, CUL3, DURS1, CA8, FOXL2, COL25A1, CPA6, 
FGF9, PHOX2A, CECR2, CDX2, IFNG, 
ARX, CREBBP, KIR2DL1, HLA-DRB5, SCD5, MOCS3, 
BCAS4, KIR2DL4, KIR3DL3, CHRNB3, REV3L, PLXND1, 
PIEZO2, MBS1, MBS3, MT-TA, EYA1, FGF13, EP300, 
ROBO3, PHOX2A, 
KIF21A, UBC 
CHL1, ELOC, 
ELOB, CHL1-AS2, 
ROBO3 
TIMP2,  TGFBI 
 
L1CAM, DRD2, GJA1, NEUROG1, EPHA4, STAT1, 
KIR3DP1, HOXD3, GZMB, UBA2, ECEL1, ADAM17, 
PTPRN2, ROBO3, TOLLIP, XIRP2, BTRC, LBX1, HGS, 
HOXD1 
 
Table 2: Identification of Hub proteins 
Degree Centrality Betweenness Centrality Closeness Centrality 
Gene Score Gene Score Gene Score 
DRD2 3560.0 DRD2 1.3852736E8 EGFR 1.2288813E-4 
DRD2 3226.0 DRD2 9.7794936E7 ARRB2 1.2288793E-4 
UBC 1609.0 UBC 6.9540432E7 UBC 1.2288745E-4 
ADAM17 1273.0 ADAM17 4.7671964E7 DRD2 1.2288734E-4 
PHAZE 1215.0 CUL3 4.2251952E7.0 CALM2 1.2288698E-4 
UBC 1188.0 EGFR 3.4354112E7 CALM2 1.2288698E-4 
CUL3 1176.0 UBC 2.9233554E7 CALM3 1.2288698E-4 
Ubc 817.0 UBC 2.7864122E7 CUL3 1.2288621E-4 
AI194771 785.0 UBC 2.567804E7 FLINA 1.2288503E-4 
UBC 719.0 ARRB2 2.0969964E7 HGS 1.2288491E-4 
 
Table 3: Module analysis 
Module 1 Module 2  
 
Module 3 Module 4 Module 5 Module 6 Module 7 
ASB-3, ASB7, 
C2orf5, CCT-
epsilon, CCT2, 
CCT3, 
CCTETA, 
COPS6, 
CUL4A, Cctq, 
EWS, GFPT2, 
HSAL2, 
KIF21A, 
MRXHF2, 
NCOA-62, 
OABP, OCT4, 
P1.1-MCM3, 
PHA2E, POP1, 
RP11-435J19.1, 
SIII, SRB, 
TCP20, p59ILK 
ARRB2, 
GRB2, 
HGS, 
NEDD8, 
TRAF1, 
UBC 
DmelCG12081, 
CG9291, 
CG4204, 
l(3)neo31 
Bor, 
BB138287, 
Neurog1 
CUL3, 
DAPK1, 
Kelch-like 
ECT2-
interacting 
protein, 
PIG53, 
Protein 
pp110, 
TSG101,  
UBC 
CBP, 
Early 
E1A  32 
kDa 
protein, 
KAT2B 
SIII p15, 
SIII p18, 
Ywhae 
 
Table 4 : Enrichment results 
Pathway or Process XD-score Q-value Overlap/size 
Dorso-ventral axis formation 0.18515 1.00000 1/20 
Phototransduction 0.16697 1.00000 1/22 
Olfactory transduction 0.14515 1.00000 1/25 
Bladder cancer 0.09042 1.00000 1/38 
Nucleotide excision repair 0.08039 1.00000 1/42 
Notch signaling pathway 0.08039 1.00000 1/42 
Endometrial cancer 0.06515 1.00000 1/50 
Non-small cell lung cancer 0.06358 1.00000 1/51 
Acute myeloid leukemia 0.06208 1.00000 1/52 
Endocytosis 0.05257 1.00000 3/178 
 
 
Table 5: Key transcription factors 
# 
Transcription 
Factor 
Description 
Target 
Genes  
Mode of 
Regulation 
1 CIITA 
class II, major histocompatibility complex, 
transactivator 
CREBBP Unknown 
HLA-
DRB5 
Unknown 
STAT1 Unknown 
2 TFAP4 
transcription factor AP-4 (activating enhancer 
binding protein 4) 
IFNG Unknown 
SALL2 Activation 
3 RFX5 
regulatory factor X, 5 (influences HLA class 
II expression) 
HLA-
DRB5 
Unknown 
IFNG Unknown 
4 SOX2 SRY (sex determining region Y)-box 2 
BMP4 Repression 
TUBB3 Repression 
5 POU5F1 POU class 5 homeobox 1 
BMP4 Repression 
CDX2 Repression 
6 REST RE1-silencing transcription factor 
STAT1 Repression 
TUBB3 Repression 
TUBB3 Unknown 
7 GATA3 GATA binding protein 3 
CDX2 Activation 
IFNG Unknown 
8 STAT3 
signal transducer and activator of transcription 
3 (acute-phase response factor) 
IFNG Repression 
SALL4 Activation 
STAT1 Activation 
9 JUN jun proto-oncogene 
GJA1 Activation 
IFNG Activation 
IFNG Unknown 
TIMP2 Unknown 
10 EP300 E1A binding protein p300 
CREBBP Unknown 
IFNG Activation 
 
In this study, a total of 76 DRS, HGPPS and CFEOM3 associated genes were identified from 
GeneCards, STICH and CTD databases (Table 1) and their protein-protein interaction network 
was constructed (Figure 1). Based on Betweenness Centrality, Closeness Centrality, and Degree 
Centrality scores DRD2, UBC and CUL3 were established as hub nodes in the Protein-Protein 
Interaction network of these genes and their interactions (Table 2). Seven distinct modules 
(Module 1, Module 2, Module 3, Module 4, Module 5, Module 6 and Module7) of the PPI 
network were identified (Figure 2). Dorso-ventral axis formation, Phototransduction, Olfactory 
transduction, Bladder cancer and Nucleotide excision repair were the top 5 pathways/processes 
the proteins in these modules were found to be significantly involved in (Table 3).  Top 10 
transcription factors targeting DRS, HGPPS and CFEOM3 associated genes have been identified 
from TRRUST database of transcription factors (Table 5).  
 
One of the key players identified in this study is the D2 dopamine receptor (DRD2). It is one of 
the most extensively studied genes implicated in neuropsychiatric disorders. Since its association 
with the TaqI A DRD2 minor (A1) allele with severe alcoholism in 1990, a number of studies 
have been carried out (Noble 2003). DR2 have been found to be associated with schizophrenia 
(Shaikh et al. 1994), posttraumatic stress disorder (PTSD) (Comings et al. 1991, 1996), 
movement disorders (Planté-Bordeneuve et al. 1997) and so on. UBC is responsible for 
maintaining cellular ubiquitin levels under stress conditions (Ryu et al. 2007).  Transcription 
of UBC gene is induced during times of stress and helps removing damaged/unfolded proteins 
(Ryu et al. 2007). Disruption of ubiquitination a mechanism which controls many aspects of 
neuronal function by regulating protein abundance in neurons has been demonstrated in 
neurological disorders such as Parkinson’s disease, Amyotrophic Lateral Sclerosis and 
Angleman Syndrome (Hallengren, Chen, and Wilson 2013). CUL3 has been found to be a key 
regulators of sleep homeostasis and a dopamine arousal pathway in drosophila (Pfeiffenberger 
and Allada 2012). CUL3 is a member of the Cullin family of proteins whose job is to function 
as scaffold proteins of E3 ubiquitin ligase complexes. One study showed revealed cell-
autonomous involvement of CUL3 in axonal arborization and dendritic elaboration of 
Drosophila mushroom body neurons. CUL3 mutant neurons were found to be defective in 
terminal morphogenesis of neurites (Zhu et al. 2005). 
 
Therefore, the three key proteins identified in this study had been implicated in various 
neurological functions and disorders before but their role in axon guidance related disorders 
were not elucidated. This new result from the perspective of Systems Biology will hopefully 
inspire in vitro investigators to extract further information about the role of these proteins in 
propagating diseases like DRS, HGPPS and CFEOM3. 
 
Conclusion 
To conclude, a total of 76 DRS, HGPPS and CFEOM3 associated genes have been identified. 
DRD2, UBC and CUL3 have been revealed as key players in DRS, HGPPS and CFEOM3 
associated pathways.  
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